Beta-thalassemia: renal complications and mechanisms: a narrative review

被引:36
作者
Demosthenous, Christos [1 ,2 ]
Vlachaki, Efthymia [3 ]
Apostolou, Chrysa [3 ]
Eleftheriou, Perla [4 ]
Kotsiafti, Aggeliki [3 ]
Vetsiou, Evangelia [3 ]
Mandala, Evdokia [5 ]
Perifanis, Vassilios [6 ]
Sarafidis, Pantelis [7 ]
机构
[1] Gen Hosp Thessaloniki George Papanicolaou, Dept Hematol, Thessaloniki, Greece
[2] Gen Hosp Thessaloniki George Papanicolaou, HCT Unit, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Hippokration Hosp, Dept Internal Med 2, Adults Thalassemia Unit, Thessaloniki, Greece
[4] UCL, Dept Haematol, London, England
[5] Aristotle Univ Thessaloniki, Hippokration Hosp, Dept Internal Med 4, Thessaloniki, Greece
[6] Aristotle Univ Thessaloniki, AHEPA Gen Hosp Thessaloniki, Propedeut Dept Internal Med 1, Thessaloniki, Greece
[7] Aristotle Univ Thessaloniki, Hippokration Hosp, Dept Nephrol, Thessaloniki, Greece
关键词
Beta-thalassemia; renal complications; iron chelators; GELATINASE-ASSOCIATED LIPOCALIN; GLOMERULAR-FILTRATION-RATE; BONE-MINERAL DENSITY; SERUM CYSTATIN-C; IRON OVERLOAD; FANCONI SYNDROME; TUBULAR DYSFUNCTION; PEDIATRIC-PATIENTS; CHELATION-THERAPY; KIDNEY-FUNCTION;
D O I
10.1080/16078454.2019.1599096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Beta-thalassemias are a group of recessively autosomal inherited disorders of hemoglobin synthesis, which, due to mutations of the beta-globin gene, lead to various degrees of defective beta-chain production, an imbalance in alpha/beta-globin chain synthesis, ineffective erythropoiesis, and anemia. Improved survival in thalassemic patients has led to the emergence of previously unrecognized complications, such as renal disease. Methods: A comprehensive literature review through PubMed was undertaken to summarize the published evidence on the epidemiology and pathophysiology of renal disease in thalassemia. Literature sources published in English since 1990 were searched, using the terms beta-thalassemia, renal disease. Results: Renal disease is considered to be the 4th cause of morbidity among patients with transfusion dependent thalassemia. Chronic anemia, hypoxia and iron overload are the main mechanisms implicated in development of renal injury, whereas several studies also suggested a contributive role of iron chelators. Discussion and Conclusion: Kidney disease may develop through progressive renal tubular and glomerular damage; thus, its early recognition is important in order to prevent and/or reverse deterioration. This review will provide an insight on the involved mechanisms implicated in kidney disease in thalassemic patients and will discuss the updates on diagnosis and prevention of renal complications in thalassemia.
引用
收藏
页码:426 / 438
页数:13
相关论文
共 101 条
[1]   Infection due to Yersinia enterocolitica in a series of patients with β-thalassemia:: Incidence and predisposing factors [J].
Adamkiewicz, TV ;
Berkovitch, M ;
Krishnan, C ;
Polsinelli, C ;
Kermack, D ;
Olivieri, NF .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) :1362-1366
[2]  
Ahmadzadeh A, 2011, SAUDI J KIDNEY DIS T, V22, P497
[3]   Correlation of Iron Overload and Glomerular Filtration Rate Estimated by Cystatin C in Patients with β-Thalassemia Major [J].
Al-Khabori, Murtadha ;
Bhandari, Sunil ;
Al-Rasadi, Khalid ;
Mevada, Surekha ;
Al-Dhuhli, Hamoud ;
Al-Kemyani, Nasser ;
Daar, Shahina .
HEMOGLOBIN, 2014, 38 (05) :365-368
[4]  
Al-Khabori Murtadha, 2013, Oman Med J, V28, P121, DOI 10.5001/omj.2013.31
[5]   Renal function in pediatric patients with β-thalassemia major [J].
Aldudak, B ;
Bayazit, AK ;
Noyan, A ;
Özel, A ;
Anarat, A ;
Sasmaz, I ;
Kilinç, Y ;
Gali, E ;
Anarat, R ;
Dikmen, N .
PEDIATRIC NEPHROLOGY, 2000, 15 (1-2) :109-112
[6]   ROLE OF IRON AND OXYGEN RADICALS IN THE PROGRESSION OF CHRONIC-RENAL-FAILURE [J].
ALFREY, AC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :183-187
[7]  
Ali Derakhshan, 2008, Saudi J Kidney Dis Transpl, V19, P206
[8]   Urinary zinc excretion and zinc status of patients with β-thalassemia major [J].
Aydinok, Y ;
Coker, C ;
Kavakli, K ;
Polat, A ;
Nisli, G ;
Cetiner, N ;
Kantar, M ;
Çetingül, N .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1999, 70 (02) :165-172
[9]   Deferasirox in thalassemia patients with end-stage renal disease [J].
Beydoun, Hassan G. ;
Saliba, Antoine N. ;
Taher, Ali T. .
AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (10) :E456-E457
[10]   Renal aspects of thalassaemia a changing paradigm [J].
Bhandari, Sunil ;
Galanello, Renzo .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (03) :187-197